Alkem Laboratories appoints Amrut Naik as CEO, effective November 11
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Alkem Laboratories appointed Amrut Naik as its new Chief Executive Officer, effective November 11.
- ✓The board approved this move on November 3 following a committee recommendation.
- ✓Naik brings over 25 years of pharmaceutical industry experience to the role, having previously held leadership positions at Zydus Group and Lupin Pharmaceuticals.
Story at a Glance
- Category
- BUSINESS
- Reported By
- cnbctv18
- Reading Speed
- 2 Minute(s)
- Market Focus
- India Economy
Alkem Laboratories has appointed Amrut Naik as its Chief Executive Officer (CEO) and Key Managerial Personnel, with effect from November 11, 2026.
A CNBC-TV18 Newsbreak on the appointment has now been confirmed as Alkem's board of directors approved the appointment at a meeting held on November 3, following a recommendation from its Nomination and Remuneration Committee.
Naik brings over 25 years of experience in the pharmaceutical industry, having held leadership positions at Zydus Group and Lupin Pharmaceuticals, among others. He most recently served as President of Zydus Group, a position he held from July 2016 to November 2026.
Naik's leadership journey
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
cnbctv18
Read the full, original unfiltered story directly on the publisher's portal.